Russian scientists have created a new anti-virus drug that they allege can help neutralize the potentially deadly H5N1 bird flu virus.
The Russian news agency ITAR-Tass reported scientists from the Russian Academy of Medical Sciences and the Russian Academy of Sciences developed the new drug that is far superior to current treatments.
Called Triazoverin, the academy's newest creation must wait for official state approval.
Russian Academy of Medical Sciences official Oleg Kiselev said the drug represents "a major achievement of Russian science and a result of fruitful cooperation of the two leading institutes of the Russian Academy of Sciences and the Russian Academy of Medical Sciences."
He added the new drug is unique in its ability to act at any stage of an infection, no matter how severe.
ITAR-Tass said the development project won funding from the Science of the Russian Federation and the Russian Ministry of Education.
Copyright 2007 by United Press International
Related stories:
Expedition 18 Crew To Launch from Baikonur
(PhysOrg.com) -- Commander Edward Michael "Mike" Fincke and Flight Engineer Yury Valentinovich Lonchakov of the 18th International Space Station crew are scheduled to launch in their Soyuz TMA-13 from the Baikonur Cosmodrome in Kazakhstan about 3 a.m. EDT Sunday to begin a six-month stay in space.
Gene with probable role in human susceptibility to pulmonary tuberculosis identified
A new gene that may confer susceptibility to pulmonary tuberculosis has been identified by Genome Institute of Singapore (GIS) researchers and their collaborators in The Netherlands, Indonesia, United Kingdom, and the Russian Federation.
Groundbreaking, lifesaving TB vaccine a step closer
Researchers at Aberystwyth University, following a number of years of investment by the Biotechnology and Biological Sciences Research Council (BBSRC), have licensed ground-breaking research to a non-profit product development partnership working to develop new, more effective vaccines against Tuberculosis (TB). This development will give hope that significantly better prevention and treatment of TB will be available within the next few years.
Vietnam finds tainted products from China
(AP) -- Vietnam's health ministry has discovered the industrial chemical melamine in 18 food products imported from China and three other countries and has ordered them recalled and destroyed, officials said Friday.
Early study reveals promising Alzheimer's disease treatment
A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal
The Lancet.
Researchers: Program discourages HIV transmission in Russia
(Boston)-Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found that sexual behavior counseling during drug addiction treatment should be considered an important component among Russian substance-dependent individuals, in order to decrease risky sexual behavior in the HIV at-risk population. This study appears in the journal
Addiction.
Can a Polymer Help Curb Arctic Ice Melting?
In order to help prevent the melting of Arctic ice, a process that has been occurring at alarming rates in recent years, which many scientists believe is due gradual global warming, a group of researchers have proposed a partial solution that is quite novel: covering select small regions with a layer of a porous polymer that would reflect sunlight and promote freezing, thereby reducing melting.
Expedition 17 Docks to International Space Station
Commander Sergei Alexandrovich Volkov and cosmonaut Oleg Dmitrievich Kononenko of the 17th International Space Station crew docked their Soyuz TMA-12 with the orbiting laboratory's Pirs Docking Compartment at 8:57 a.m. EDT Thursday, marking the beginning of their six-month stay aboard.